Signant's Solutions Improve HIV Clinical Trial Experience

Signant’s innovative clinical trial technologies help researchers improve the quality of life for people living with HIV (PLWHIV) by advancing antiretroviral therapies (ART).

We help Human Immunodeficiency Virus (HIV) studies:

• Achieve optimal adherence
• Reduce burdens for sites & study teams
• Maximize IP supply chain efficiency
• Collect objective measures on activity & sleep
• Enable accurate ClinROs

Take a look at our HIV brochure for more details on how we can help studies like yours.